Libmeldy: ‘Significant Discount’ For World’s Most Expensive Drug Secures English Funding

US Filing Planned In Late 2022 Or Early 2023

Genetic Medicine with dna isolated on white.
Libmeldy is a gene therapy for metachromatic leukodystrophy • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United Kingdom

More from Europe